Respiratory syncytial virus (RSV) kills around 200,000 people worldwide each year. Both the elderly and infants are especially vulnerable to developing severe disease with RSV. Two-thirds of babies are infected with RSV before their first birthday and in winter the virus causes annual epidemics resulting in up to 15 out of every 100 admissions to children's wards. In the world’s poorer areas, RSV is second only to malaria as a killer of children aged between 1 and 12 months.
Volunteers sought for study into vaccine for serious childhood infection
10 November 2015
Oxford University researchers are looking for healthy adults to take part in the initial trial of a potential new vaccine against a virus considered to be a crucial missing element in the childhood vaccination programme.